CD22 CAR T Cell-Related IEC-HS Is Associated with an IFN-. Cytokine Signature

被引：2
|
作者：
Srinagesh, Hrishikesh [1 ]
Baird, John H. [2 ]
Agarwal, Neha [1 ]
Su, Yi-Jiun [1 ]
Kramer, Anne Marijn [3 ]
Reschke, Agnes [1 ]
Jeyakumar, Nikeshan [1 ]
Bharadwaj, Sushma [1 ]
Schultz, Liora Michal [4 ]
Ramakrishna, Sneha [5 ]
Davis, Kara L. [6 ]
Sahaf, Bita [7 ]
Feldman, Steven [3 ]
Mackall, Crystal L. [8 ]
Miklos, David B. [9 ]
Muffly, Lori S. [1 ]
Frank, Matthew J. [9 ]
机构：
[1] Stanford Univ, Div Blood & Marrow Transplantat Cellular Therapy, Sch Med, Palo Alto, CA USA
[2] City Hope Natl Med Ctr, Dept Hematol & HCT, Duarte, CA USA
[3] Stanford Univ, Ctr Canc Cell Therapy, Stanford, CA USA
[4] Stanford Univ, Div Hematol & Oncol, Dept Pediat, Sch Med, Palo Alto, CA USA
[5] Stanford Univ, Div Hematol & Oncol, Dept Pediat, Sch Med, Palo Alto, CA USA
[6] Stanford Univ, Dept Pediat Hematol Oncol & Stem Cell Transplant, Stanford, CA USA
[7] Stanford Univ, Canc Correlat Sci Unit, Palo Alto, CA USA
[8] Stanford Univ, Stanford Canc Inst, Ctr Canc Cell Therapy, Stanford, CA USA
[9] Stanford Univ, Div Blood & Marrow Transplantat Cellular Therapy, Palo Alto, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-178283
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment
    Guo, Yelei
    Feng, Kaichao
    Tong, Chuan
    Jia, Hejin
    Liu, Yang
    Wang, Yao
    Ti, Dongdong
    Yang, Qingming
    Wu, Zhiqiang
    Han, Weidong
    CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (04) : 430 - 432
  • [42] Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment
    Yelei Guo
    Kaichao Feng
    Chuan Tong
    Hejin Jia
    Yang Liu
    Yao Wang
    Dongdong Ti
    Qingming Yang
    Zhiqiang Wu
    Weidong Han
    Cellular & Molecular Immunology, 2020, 17 : 430 - 432
  • [43] Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis
    Komal Adeel
    Nathan J. Fergusson
    Risa Shorr
    Harold Atkins
    Kevin A. Hay
    Systematic Reviews, 10
  • [44] Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis
    Adeel, Komal
    Fergusson, Nathan J.
    Shorr, Risa
    Atkins, Harold
    Hay, Kevin A.
    SYSTEMATIC REVIEWS, 2021, 10 (01)
  • [45] CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T Therapy
    Yu, Xinjian
    Li, Pan
    Feng, Heyuan
    Kang, Jian
    Zheng, Xichang
    Zhang, Yunmei
    Yang, Wenhong
    Wu, Tong
    Liu, Shuangyou
    BLOOD, 2020, 136
  • [46] Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
    Hanren Dai
    Zhiqiang Wu
    Hejin Jia
    Chuan Tong
    Yelei Guo
    Dongdong Ti
    Xiao Han
    Yang Liu
    Wenying Zhang
    Chunmeng Wang
    Yajing Zhang
    Meixia Chen
    Qingming Yang
    Yao Wang
    Weidong Han
    Journal of Hematology & Oncology, 13
  • [47] Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients
    Qu, Changju
    Zou, Rui
    Wang, Peng
    Zhu, Qian
    Kang, Liqing
    Ping, Nana
    Xia, Fan
    Liu, Hailing
    Kong, Danqing
    Yu, Lei
    Wu, Depei
    Jin, Zhengming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report
    Sun, Yao
    Su, Yongfeng
    Wang, Yizhi
    Liu, Na
    Li, Yuhang
    Chen, Jianlin
    Qiao, Zhuoqing
    Niu, Jingwen
    Hu, Jiangwei
    Zhang, Bin
    Ning, Hongmei
    Hu, Liangding
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [49] Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Kong, Delin
    Geng, Jia
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [50] CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study
    Jiahua Niu
    Huiying Qiu
    Fang Xiang
    Lin Zhu
    Jun Yang
    Chongmei Huang
    Kun Zhou
    Yin Tong
    Yu Cai
    Baoxia Dong
    Yuan Lu
    Xuedong Sun
    Liping Wan
    Xueying Ding
    Haopeng Wang
    Xianmin Song
    Blood Cancer Journal, 13
12345